RESEARCH TRIANGLE PARK, N.C., Dec. 13, 2022 -- Pappas Capital, a global venture capital and commercial development firm, announced today the appointment of Richard Staub as Venture Partner. His appointment...
TargeGen successfully completed enrollment of a multi-center clinical trial of TG101348
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.